Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

J Transl Med. 2023 May 25;21(1):347. doi: 10.1186/s12967-023-04203-6.

Abstract

Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.

Keywords: Cardiovascular diseases; Ischemia reperfusion injury; Mitochondrial dysfunction; Mitochondrial transplantation; Therapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / therapy
  • Humans
  • Mitochondria